# Celanese Corp: Form 10-Q for the period ended Mar 31, 2020

- Company: [Celanese Corp](/companies/ce.md) (CIK 1306830)
- Form: 10-Q
- Filed: 2020-04-28
- Accepted by EDGAR: Apr 28, 2020, 16:19 ET
- Period: 2020-03-31
- Accession: 0001306830-20-000105
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1306830/000130683020000105/ce-10q33120.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1306830/000130683020000105/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $1.46bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-01-01 to 2020-03-31 | $1.11bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-01-01 to 2020-03-31 | $348.0m | us-gaap:GrossProfit |
| Research and development | 3 months, 2020-01-01 to 2020-03-31 | $17.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2020-01-01 to 2020-03-31 | $125.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-01-01 to 2020-03-31 | $194.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-01-01 to 2020-03-31 | $28.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-01-01 to 2020-03-31 | $65.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | $218.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-01-01 to 2020-03-31 | $1.82 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-01-01 to 2020-03-31 | $1.83 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-01-01 to 2020-03-31 | 119,899,844 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2020-01-01 to 2020-03-31 | $259.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2020-01-01 to 2020-03-31 | $119.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2020-01-01 to 2020-03-31 | $74.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2020-01-01 to 2020-03-31 | $167.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2020-03-31 | $2.85bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $9.54bn | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $1.93bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2020-03-31 | $3.36bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-03-31 | $749.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2020-03-31 | $2.45bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 37,167 characters.

*In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese US" refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.*

*The following discussion should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the year ended December 31, 2019 filed on February 6, 2020 with the Securities and Exchange Commission ("SEC") as part of the Company's Annual Reporting on Form 10-K ("2019 Form 10-K") and the unaudited interim consolidated financial statements and notes to the unaudited interim consolidated financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America ("US GAAP").*

*Investors are cautioned that the forward-looking statements contained in this section and other parts of this Quarterly Report involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See "Forward-Looking Statements" below and at the beginning of our 2019 Form 10-K.*

### Forward-Looking Statements

Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and other parts of this Quarterly Report contain certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. Generally, words such as "believe," "expect," "intend," "estimate," "anticipate," "project," "plan," "may," "can," "could," "might," and "will," and similar expressions, as they relate to us are intended to identify forward-looking statements. These statements reflect our current views and beliefs with respect to future events at the time that the statements are made, are not historical facts or guarantees of future performance and involve risks and uncertainties that are difficult to predict and many of which are outside of our control. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements made in this Quarterly Report are made as of the date hereof, and the risk that actual results will differ materially from expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation, and disclaim any duty, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in our expectations or otherwise.

### COVID-19 Update

On March 11, 2020, the World Health Organization declared the outbreak of a novel coronavirus ("COVID-19") as a pandemic, which continues to spread throughout the world, creating a dynamic and challenging situation worldwide. COVID-19 originated in China and has spread to other countries where we have offices and production facilities as well as customers and suppliers. The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home restrictions, travel restrictions and other public health safety measures.

Our employees' health and well-being continue to be of vital importance. We have implemented contingency planning, and employees who can work remotely are doing so from their homes. For employees who are considered essential and are working in plants, we have implemented government recommended protocols and best practices related to social distancing and best hygiene practices, including the use of additional personal protective equipment, where appropriate. We have a global crisis team in place monitoring the rapidly evolving situation and recommending risk mitigation actions, including the implementation of travel restrictions. Our presence in China provided us with an advance view of how COVID-19 scenarios can unfold as well as the importance of taking early action.

We operate within a geographically-balanced global footprint and have the ability to utilize different production and distribution strategies depending on the business and product to satisfy customer demands. We continue to pursue our existing operational strategy. Since our industry is considered essential by the local government in the majority of the areas we operate, most of our plants continue to be operational, and we have been able to maintain a largely consistent supply chain. However, as customer demand has weakened, we have temporarily reduced run rates at certain of our plants to reduce costs and inventory levels. During the three months ended March 31, 2020, the effects of COVID-19 and related actions to control its spread had a negative impact on our operating results, primarily in the Acetyl Chain segment, as discussed in more detail in the individual reporting segment sections below. We expect the declines in consumer demand, particularly in the Western Hemisphere, to work through the relevant value chains in the second fiscal quarter of 2020. In Engineered Materials, our most impacted end markets reflect a significant decrease in big-ticket discretionary spending among consumers for items such as automobiles, electronics and appliances. Other application areas including food and beverage, medical, pharma and 5G infrastructure are more resilient. In the Acetyl Chain, we benefit from a highly diversified set of end-uses with less exposure, relative to others in the industry, to end markets that are more acutely impacted by COVID-19, like automotive. At the same time, we see resiliency and even growth in some applications including water bottles, packaging, hygiene products, disinfectants, pharma and cigarettes. However, the historically low acetic acid pricing, along with the recent developments with global oil markets, continue to present a deflationary environment for the Acetyl Chain business. We anticipate that our operations will continue to be negatively impacted through at least our second fiscal quarter of 2020, as the economies in which we operate hopefully begin to recover from COVID-19. We currently anticipate that customer demand and our results of our operations should begin to normalize in the second half of fiscal 2020, absent a similar resurgence of COVID-19. The extent to which COVID-19 will adversely impact our business, financial condition and results of operations will depend on numerous evolving factors, which are highly uncertain, rapidly changing and cannot be predicted. For further information regarding the impact COVID-19 could have on our business, financial condition and results of operations, see *Part II - Item 1A. Risk Factors.*

### Risk Factors

See *Part I - Item 1A. Risk Factors* of our 2019 Form 10-K and subsequent periodic filings we make with the SEC for a description of certain risk factors that you should consider which could significantly affect our financial results. In addition, the following factors could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements. These factors include, among other things:

- changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate;
- the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries;
- changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources;
- the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases;
- the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance;
- the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants;
- increased price competition and the introduction of competing products by other companies;
- the ability to identify desirable potential acquisition targets and to consummate acquisition or investment transactions, including obtaining regulatory approvals, consistent with our strategy;
- market acceptance of our technology;
- the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us;
- changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations that may impact recorded or future tax impacts associated with the Tax Cuts and Jobs Act (the "TCJA");
- changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property;
- compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest, public health crises (including, but not limited to, the coronavirus outbreak), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather, natural disasters, or other crises including public health crises;
- potential liability for remedial actions and increased costs under existing or future environmental regulations, including those relating to climate change;
- potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate;
- changes in currency exchange rates and interest rates;
- our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and
- various other factors, both referenced and not referenced in this Quarterly Report.

Many of these factors are macroeconomic in nature and are, therefore, beyond our control. In addition, COVID-19 and responses to the pandemic by governments and businesses, have significantly increased financial and economic volatility and uncertainty, exacerbating the risks and potential impact of these factors. Should one or more of these risks or uncertainties materialize, affect us in ways or to an extent that we currently do not expect or consider to be significant, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates.

### Overview

We are a global chemical and specialty materials company. We are a leading global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals, for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, consumer and medical, energy storage, filtration, food and beverage, paints and coatings, paper and packaging, performance industrial and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures.

Our large and diverse global customer base primarily consists of major companies across a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track record of execution, strong performance built on differentiated business models and a clear focus on growth and value creation. Known for operational excellence, reliability and execution of our business strategies, we partner with our customers around the globe to deliver best-in-class technologies and solutions.

### Results of Operations

#### Financial Highlights

*(unaudited)*

*(In $ millions, except percentages)*

| Statement of Operations Data | Three Months Ended March 31, 2020 | 2019 | Change |
| --- | ---: | ---: | ---: |
| Net sales | 1,460 | 1,687 | (227) |
| Gross profit | 348 | 453 | (105) |
| Selling, general and administrative ("SG&A") expenses | (125) | (120) | (5) |
| Other (charges) gains, net | (6) | 4 | (10) |
| Operating profit (loss) | 194 | 320 | (126) |
| Equity in net earnings (loss) of affiliates | 57 | 50 | 7 |
| Non-operating pension and other postretirement employee benefit (expense) income | 28 | 17 | 11 |
| Interest expense | (28) | (31) | 3 |
| Dividend income - equity investments | 37 | 32 | 5 |
| Earnings (loss) from continuing operations before tax | 292 | 385 | (93) |
| Earnings (loss) from continuing operations | 227 | 339 | (112) |
| Earnings (loss) from discontinued operations | (7) | (1) | (6) |
| Net earnings (loss) | 220 | 338 | (118) |
| Net earnings (loss) attributable to Celanese Corporation | 218 | 337 | (119) |
| **Other Data** |  |  |  |
| Depreciation and amortization | 85 | 83 | 2 |
| SG&A expenses as a percentage of Net sales | 8.6% | 7.1% |  |
| Operating margin(1) | 13.3% | 19.0% |  |
| Other (charges) gains, net |  |  |  |
| Restructuring | (6) | 1 | (7) |
| Asset impairments | (4) | — | (4) |
| Plant/office closures | (1) | (1) | — |
| Commercial disputes | 5 | 4 | 1 |
| Total Other (charges) gains, net | (6) | 4 | (10) |

(1) Defined as Operating profit (loss) divided by Net sales.

*(unaudited)*

| Balance Sheet Data | As of March 31, 2020 (In $ millions) | As of December 31, 2019 |
| --- | ---: | ---: |
| Cash and cash equivalents | 570 | 463 |
| Short-term borrowings and current installments of long-term debt - third party and affiliates | 749 | 496 |
| Long-term debt, net of unamortized deferred financing costs | 3,356 | 3,409 |
| Total debt | 4,105 | 3,905 |

39

### Factors Affecting Business Segment Net Sales

The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows:

#### Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019

*(unaudited)*

|  | Volume (In percentages) | Price | Currency | Other | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| Engineered Materials | (9) | (5) | (1) | — | (15) |
| Acetate Tow | (17) | (5) | — | — | (22) |
| Acetyl Chain | (3) | (7) | (1) | 1 | (10) |
| Total Company | (7) | (6) | (1) | 1 | (13) |

### Consolidated Results

#### Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019

Net sales decreased $227 million, or 13%, for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower volume across all of our segments, primarily driven by a continued reduction in the customer demand environment in Asia, which was impacted by the COVID-19 pandemic, in our Acetyl Chain segment, as well as continued deterioration of global economic conditions in our Engineered Materials segment;
- lower pricing in our Acetyl Chain and Engineered Materials segments; and
- an unfavorable currency impact in our Acetyl Chain and Engineered Materials segments.

Operating profit decreased $126 million, or 39%, for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower Net sales across all of our segments; and
- higher spending in our Engineered Materials and Acetyl Chain segments;

partially offset by:

- lower raw material costs within our Engineered Materials and Acetyl Chain segments.

Equity in net earnings (loss) of affiliates increased $7 million for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- an increase in equity investment in earnings of $8 million from our Ibn Sina strategic affiliate, primarily as a result of decreased plant turnaround activity.

Our effective income tax rate for the three months ended March 31, 2020 was 22% compared to 12% for the same period in 2019. The higher effective income tax rate for the three months ended March 31, 2020 compared to the same period in 2019 was primarily due to the impact of functional currency differences in offshore jurisdictions and changes in the jurisdictional mix of earnings.

See Note 13 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

### Business Segments

### Engineered Materials

*(unaudited)*

*(In $ millions, except percentages)*

|  | Three Months Ended March 31, 2020 | 2019 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 563 | 663 | (100) | (15.1)% |
| **Net Sales Variance** |  |  |  |  |
| Volume | (9)% |  |  |  |
| Price | (5)% |  |  |  |
| Currency | (1)% |  |  |  |
| Other | —% |  |  |  |
| Other (charges) gains, net | — | 15 | (15) | (100.0)% |
| Operating profit (loss) | 102 | 144 | (42) | (29.2)% |
| Operating margin | 18.1% | 21.7% |  |  |
| Equity in net earnings (loss) of affiliates | 53 | 46 | 7 | 15.2% |
| Depreciation and amortization | 34 | 32 | 2 | 6.3% |

Our Engineered Materials segment includes our engineered materials business, our food ingredients business and certain strategic affiliates. Our engineered materials business develops, produces and supplies a broad portfolio of high performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Together with our strategic affiliates, our engineered materials business is a leading participant in the global specialty polymers industry. Our food ingredients business is a leading global supplier of acesulfame potassium for the food and beverage industry and is a leading producer of food protection ingredients, such as potassium sorbate and sorbic acid.

The pricing of products within the Engineered Materials segment is primarily based on the value of the material we produce and is generally independent of changes in the cost of raw materials. Therefore, in general, margins may expand or contract in response to changes in raw material costs.

#### Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019

Net sales decreased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower volume for most of our products driven by continued deterioration of global economic conditions;
- lower pricing for most of our products, primarily due to a continued reduction in customer demand, as well as customer and product mix; and
- an unfavorable currency impact resulting from a weaker Euro relative to the US dollar.

Operating profit decreased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower Net sales;
- an unfavorable impact to Other (charges) gains, net. During the three months ended March 31, 2019, we recorded a $15 million gain related to a settlement of a commercial dispute from a previous acquisition, which did not recur in the current year. See Note 12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information; and
- higher spending costs of $11 million, primarily as a result of higher maintenance costs and plant turnaround activity;

partially offset by:

- lower raw material costs for most of our products.

Equity in net earnings (loss) of affiliates increased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- an increase in equity investment in earnings of $8 million from our Ibn Sina strategic affiliate, primarily as a result of decreased plant turnaround activity.

### Acetate Tow

*(unaudited)*

*(In $ millions, except percentages)*

|  | Three Months Ended March 31, 2020 | 2019 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 129 | 166 | (37) | (22.3)% |
| **Net Sales Variance** |  |  |  |  |
| Volume | (17)% |  |  |  |
| Price | (5)% |  |  |  |
| Currency | —% |  |  |  |
| Other | —% |  |  |  |
| Other (charges) gains, net | (1) | — | (1) | (100.0)% |
| Operating profit (loss) | 27 | 40 | (13) | (32.5)% |
| Operating margin | 20.9% | 24.1% |  |  |
| Dividend income - equity investments | 37 | 32 | 5 | 15.6% |
| Depreciation and amortization | 8 | 10 | (2) | (20.0)% |

Our Acetate Tow segment serves consumer-driven applications. We are a leading global producer and supplier of acetate tow and acetate flake, primarily used in filter products applications.

The pricing of products within the Acetate Tow segment is sensitive to demand and is primarily based on the value of the product we produce. Many sales in this business are conducted under contracts with pricing for one or more years. As a result, margins may expand or contract in response to changes in market conditions over these similar periods, and we may be unable to adjust pricing also due to other factors, such as the intense level of competition in the industry.

#### Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019

Net sales decreased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower acetate flake volume, primarily due to the expiration of an acetate flake contract;
- lower acetate tow volume, consistent with global demand reduction; and
- lower acetate tow pricing, primarily due to customer mix.

Operating profit decreased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower Net sales;

partially offset by:

- lower energy costs of $7 million, primarily related to the closure of our acetate flake manufacturing unit in Ocotlán, Mexico in the prior year.

### Acetyl Chain

*(unaudited)*

*(In $ millions, except percentages)*

|  | Three Months Ended March 31, 2020 | 2019 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Net sales | 799 | 889 | (90) | (10.1)% |
| **Net Sales Variance** |  |  |  |  |
| Volume | (3)% |  |  |  |
| Price | (7)% |  |  |  |
| Currency | (1)% |  |  |  |
| Other | 1% |  |  |  |
| Operating profit (loss) | 135 | 202 | (67) | (33.2)% |
| Operating margin | 16.9% | 22.7% |  |  |
| Depreciation and amortization | 39 | 38 | 1 | 2.6% |

Our Acetyl Chain segment includes the integrated chain of intermediate chemistry, emulsion polymers and ethylene vinyl acetate ("EVA") polymers businesses. Our intermediate chemistry business produces and supplies acetyl products, including acetic acid, vinyl acetate monomer ("VAM"), acetic anhydride and acetate esters. These products are generally used as starting materials for colorants, paints, adhesives, coatings and pharmaceuticals. It also produces organic solvents and intermediates for pharmaceutical, agricultural and chemical products. Our emulsion polymers business is a leading global producer of vinyl acetate-based emulsions and develops products and application technologies to improve performance, create value and drive innovation in applications such as paints and coatings, adhesives, construction, glass fiber, textiles and paper. Our EVA polymers business is a leading North American manufacturer of a full range of specialty EVA resins and compounds, as well as select grades of low-density polyethylene. Our EVA polymers products are used in many applications, including flexible packaging films, lamination film products, hot melt adhesives, automotive parts and carpeting.

The pricing of products within the Acetyl Chain is influenced by industry utilization rates and changes in the cost of raw materials. Therefore, in general, there is a directional correlation between these factors and our Net sales for most Acetyl Chain products. This impact to pricing typically lags changes in raw material costs over months or quarters.

#### Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019

Net sales decreased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower pricing for most of our products, primarily due to an overall deflationary environment for raw materials and a continued reduction in the customer demand environment, which was also impacted by the COVID-19 pandemic;
- lower volume for most of our products due to a continued reduction in the customer demand environment in Asia, which was also impacted by the COVID-19 pandemic, partially offset by higher volume for VAM due to increased customer demand and focus on downstream products in the Western Hemisphere; and
- an unfavorable currency impact resulting from a weaker Euro relative to the US dollar.

Operating profit decreased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower Net sales;
- higher plant turnaround costs of $14 million related to our joint venture, Fairway Methanol LLC ("Fairway"); and
- higher costs of $10 million, primarily related to plant operating costs and expansion projects;

partially offset by:

- lower raw material costs, primarily for ethylene, carbon monoxide and methanol.

### Other Activities

*(unaudited)*

*(In $ millions, except percentages)*

|  | Three Months Ended March 31, 2020 | 2019 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Other (charges) gains, net | (5) | (11) | 6 | 54.5% |
| Operating profit (loss) | (70) | (66) | (4) | (6.1)% |
| Equity in net earnings (loss) of affiliates | 3 | 3 | — | —% |
| Non-operating pension and other postretirement employee benefit (expense) income | 28 | 17 | 11 | 64.7% |
| Depreciation and amortization | 4 | 3 | 1 | 33.3% |

Other Activities primarily consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expense associated with financing activities and results of our captive insurance companies. Other Activities also includes the components of net periodic benefit cost (interest cost, expected return on assets and net actuarial gains and losses) for our defined benefit pension plans and other postretirement plans not allocated to our business segments.

#### Three Months Ended March 31, 2020 Compared to Three Months Ended March 31, 2019

Operating loss increased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- an unfavorable currency impact of $5 million resulting from a weaker Euro relative to the US dollar; and
- higher functional spending of $3 million;

largely offset by:

- a favorable impact of $6 million to Other (charges) gains, net. During the three months ended March 31, 2019 we recorded an $11 million loss related to a settlement by our captive insurer with a former third-party customer, which did not recur in the current year. This was partially offset by $5 million in employee termination benefits during the three months ended March 31, 2020, primarily related to business optimization projects. See Note 12 - Other (Charges) Gains, Net in the accompanying unaudited interim consolidated financial statements for further information.

Non-operating pension and other postretirement employee benefit income increased for the three months ended March 31, 2020 compared to the same period in 2019, primarily due to:

- lower interest cost and higher expected return on plan assets.

### Liquidity and Capital Resources

Our primary source of liquidity is cash generated from operations, available cash and cash equivalents and dividends from our portfolio of strategic investments. In addition, as of March 31, 2020, we have $1.0 billion available for borrowing under our senior unsecured revolving credit facility and $5 million available under our accounts receivable securitization facility to assist, if required, in meeting our working capital needs and other contractual obligations.

While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next twelve months. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness. There can be no assurance, however, that we will continue to generate cash flows at or above current levels.

Total cash outflows for capital expenditures are expected to be in the range of $325 million to $350 million in 2020, primarily due to additional investments in growth opportunities and productivity improvements primarily in our Engineered Materials and Acetyl Chain segments.

On a stand-alone basis, Celanese and its immediate 100% owned subsidiary, Celanese US, have no material assets other than the stock of their subsidiaries and no independent external operations of their own. Accordingly, they generally depend on the cash flow of their subsidiaries and their ability to pay dividends and make other distributions to Celanese and Celanese US in order to meet their obligations, including their obligations under senior credit facilities and senior notes and to pay dividends on our Common stock, par value $0.0001 per share ("Common Stock").

We are subject to capital controls and exchange restrictions imposed by the local governments in certain jurisdictions where we operate, such as China, India and Indonesia. Capital controls impose limitations on our ability to exchange currencies, repatriate earnings or capital, lend via intercompany loans or create cross-border cash pooling arrangements. Our largest exposure to a country with capital controls is in China. Pursuant to applicable regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, the Chinese government imposes certain currency exchange controls on cash transfers out of China, puts certain limitations on duration, purpose and amount of intercompany loans, and restricts cross-border cash pooling.

### Cash Flows

Cash and cash equivalents increased $107 million to $570 million as of March 31, 2020 compared to December 31, 2019. As of March 31, 2020, $492 million of the $570 million of cash and cash equivalents was held by our foreign subsidiaries. Under the TCJA, we have incurred a prior year charge associated with the deemed repatriation of previously unremitted foreign earnings, including foreign held cash. These funds are largely accessible without additional material tax consequences, if needed in the US, to fund operations. See Note 13 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.

- ***Net Cash Provided by (Used in) Operating Activities***

Net cash provided by operating activities decreased $48 million to $259 million for the three months ended March 31, 2020 compared to $307 million for the same period in 2019. Net cash provided by operating activities for the three months ended March 31, 2020 decreased, primarily due to:

- a decrease in net earnings;

partially offset by:

- a decrease in incentive compensation payouts of $42 million; and
- favorable trade working capital of $14 million, primarily due to an increase in trade payables related to higher capital expenditures in the current year, partially offset by an increase in inventory as a result of inventory build-up for plant turnarounds in the current year.
- ***Net Cash Provided by (Used in) Investing Activities***

Net cash used in investing activities decreased $49 million to $128 million for the three months ended March 31, 2020 compared to $177 million for the same period in 2019, primarily due to:

- a net cash outflow of $91 million related to the acquisition of Next Polymers Ltd. in January 2019;

partially offset by:

- an increase of $40 million in capital expenditures related to growth and productivity improvements in our Engineered Materials and Acetyl Chain segments.
- ***Net Cash Provided by (Used in) Financing Activities***

Net cash used in financing activities decreased $114 million to $16 million for the three months ended March 31, 2020 compared to $130 million for the same period in 2019, primarily due to:

- an increase in net borrowings on short-term debt of $76 million, due to higher borrowings during the three months ended March 31, 2020 related to us entering into an aggregate of $300 million in short-term, bilateral term loans, which were primarily used to repay borrowings under our outstanding senior unsecured revolving credit facility; and
- lower share repurchases of our Common Stock of $45 million during the three months ended March 31, 2020.

### Debt and Other Obligations

There have been no material changes to our debt or other obligations described in our 2019 Form 10-K other than those disclosed above and in Note 8 - Debt in the accompanying unaudited interim consolidated financial statements.

### Other Financing Arrangements

We have a factoring agreement with a global financial institution to sell certain accounts receivable on a non-recourse basis. These transactions are treated as a sale and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the receivables to the buyer. We have no continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. We de-recognized $69 million and $257 million of accounts receivable as of March 31, 2020 and December 31, 2019, respectively.

### Share Capital

We declared a quarterly cash dividend of $0.62 per share on our Common Stock on April 15, 2020, amounting to $73 million.

There have been no material changes to our share capital described in our 2019 Form 10-K other than those disclosed in Note 11 - Stockholders' Equity in the accompanying unaudited interim consolidated financial statements.

### Contractual Obligations

Except as otherwise described in this report, there have been no material revisions outside the ordinary course of business to our contractual obligations as described in our 2019 Form 10-K.

### Off-Balance Sheet Arrangements

We have not entered into any material off-balance sheet arrangements.

### Critical Accounting Policies and Estimates

Our unaudited interim consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results.

We describe our significant accounting policies in Note 2 - Summary of Accounting Policies, of the Notes to the Consolidated Financial Statements included in our 2019 Form 10-K. We discuss our critical accounting policies and estimates in MD&A in our 2019 Form 10-K.

### Recent Accounting Pronouncements

See Note 2 - Recent Accounting Pronouncements in the accompanying unaudited interim consolidated financial statements included in this Quarterly Report for information regarding recent accounting pronouncements.

## Market risk

As filed, 482 characters.

Market risk for the Company has not changed materially from the foreign exchange, interest rate and commodity risks disclosed in Item 7A. Quantitative and Qualitative Disclosures about Market Risk in our 2019 Form 10-K. See also Note 14 - Derivative Financial Instruments in the accompanying unaudited interim consolidated financial statements for further discussion of our market risk management and the related impact on the Company's financial position and results of operations.

## Controls and procedures

As filed, 857 characters.

### Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, as of March 31, 2020, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective.

### Changes in Internal Control Over Financial Reporting

During the period covered by this report, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 5,501 characters.

The Company is supplementing the risk factors previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2019, filed with the Securities and Exchange Commission on February 6, 2020 (the "2019 Form 10-K"), to include the following risk factor under the heading "Risks Related to Our Business."

**The extent to which the novel coronavirus ("COVID-19") pandemic or similar public health crises will adversely impact our business, financial condition and results of operations is highly uncertain and cannot be predicted.**

Public health crises such as pandemics or similar outbreaks could adversely impact our business. In December 2019, a novel strain of a virus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), or coronavirus, which causes coronavirus disease 2019, or COVID-19, surfaced in Wuhan, China and has reached multiple other regions and countries where we and our customers and suppliers have offices and production facilities. The COVID-19 pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home restrictions, travel restrictions and other public health safety measures, as well as reported adverse impacts on healthcare resources, facilities and providers. The extent to which COVID-19 impacts our operations or those of our customers or suppliers will depend on future developments and numerous factors, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, additional or modified government actions, new information that will emerge concerning the severity and impact of COVID-19 and the actions to contain COVID-19 or address its impact in the short and long term, among others.

The extent to which COVID-19 will adversely impact our business, financial condition and results of operations will depend on numerous evolving factors, which are highly uncertain, rapidly changing and cannot be predicted, including:

- the duration and scope of the outbreak;
- governmental, business and individual actions that have been and continue to be taken in response to the outbreak, including social distancing, work-at-home, stay-at-home and shelter-in-place orders and shutdowns, travel restrictions and quarantines;
- the effect of the outbreak on our customers, suppliers, supply chain and other business partners;
- our ability during the outbreak to provide our products and services, including the health and well-being of our employees;
- business disruptions caused by actual or potential plant, workplace and office closures, and an increased reliance on employees working from home, disruptions to or delays in ongoing laboratory and product testing, experiments and operations, staffing shortages, travel limitations, cyber security and data accessibility, or communication or mass transit disruptions, any of which could adversely impact our business operations or delay necessary interactions with local regulators, manufacturing sites and other important agencies and contractors;
- the ability of our customers to pay for our products and services during and following the outbreak;
- the impact of the outbreak on the financial markets and economic activity generally;
- our ability to access usual sources of liquidity on reasonable terms; and
- our ability to comply with the financial covenant in our Credit Agreement if a material economic downturn results in increased indebtedness or substantially lower EBITDA.

The COVID-19 pandemic has significantly increased financial and economic volatility and uncertainty. A continued slowdown or downturn in the economy has begun to have, and we expect will continue to have, a negative impact on many of our customers. Our operations and financial results could be materially adversely impacted to the extent that the decline in certain customer orders are materially greater than we have experienced to date during the COVID-19 pandemic, or our expenses increase due to the impact of the pandemic, including as a result of impacts on our labor costs or productivity, supply chain disruptions or future actions by governments or businesses.

The COVID-19 pandemic continues to rapidly evolve, and it is unknown how long disruptions to our business operations resulting from the COVID-19 pandemic, including any disruptions relating to the ultimate geographic spread of the disease. However, any prolonged disruption could have a material adverse impact our business, financial condition and results of operations, and we will continue to monitor the situation closely.

In addition, the trading prices for our common stock and other chemical companies have been highly volatile as a result of the COVID-19 pandemic. As a result, we may face difficulties raising capital through equity or debt financings, or such financing transactions may be on unfavorable terms.

Please also refer to the complete Item 1A of the 2019 Form 10-K filed for additional risks and uncertainties facing the Company that may have a material adverse effect on the Company's business prospects, financial condition and results of operations. The COVID-19 pandemic, and responses to the pandemic by governments and businesses, have exacerbated many of the risks and potential impact of the factors addressed in Item 1A of the 2019 Form 10-K, and may affect us in additional ways or to an extent that we currently do not expect or consider to be significant.

Filed Apr 28, 2020.
Source: SEC EDGAR, the filing index for accession 0001306830-20-000105. Last ingested by Listed: Nov 13, 2026, 16:24 ET. No prices; not investment advice.
